Several lines of evidence documented that IL-6 levels in the serum and peritoneal fluids are higher in ovarian cancer patients, and high level of IL-6 is independently associated with poor prognosis and survival of these patients [60, 61]. The gene discussed is IL6; the disease is ovarian carcinoma.